Delaware's Health Care Spending Surge: Insights and Impacts
In Delaware, health care spending surged to $11.3 billion in 2024, marking an 8.7% increase from the previous year, exceeding the state's target of a 3.0% rise. The Department of Health and Social Services’ (DHSS) latest Health Care Benchmark Trend Report revealed a per capita spending increase ranging from 6.4% to 12.2%. This significant rise underscores the challenges of managing health care costs within regulatory compliance frameworks.
Christen Linke-Young, DHSS Cabinet Secretary, stressed the need to enhance health care affordability while ensuring efficient fund utilization. She advocated for a shift towards multi-payer value-based care transformation, aiming to align incentives across hospitals, clinicians, insurance companies, and government bodies to optimize health outcomes at lower costs.
Dr. Neil Hockstein, Chair of the Delaware Health Care Commission, highlighted that the escalating expenses call for a transformative approach to care administration and financing. Emphasizing the importance of aligning incentives with preventive care, he noted the necessity of improving health outcomes through strategic risk management.
Revised Methodology and Spending Drivers
The report introduced a new methodology for calculating per capita spending, incorporating enrollment data from payers instead of traditional census-based estimates. This adjustment reflects sharper spending changes following shifts in coverage and enrollment after pandemic-related Medicaid continuous coverage ended. Data collected encompassed information from commercial insurers, Medicaid, Medicare, the Veterans Health Administration, and private health insurance carriers.
Several factors contributed to the spending rise, including inflation, pharmaceutical expenditures, hospital spending, and increased utilization of behavioral health services. Hospital services alone accounted for over $3.9 billion, nearly 36% of total healthcare spending. Medicare expenses represented approximately 42% of total expenditures, further influenced by Delaware’s aging population and changing enrollment patterns.
Quality Benchmarks and Performance
Delaware, one of eight states with a statewide health care cost growth benchmark, seeks to align healthcare spending growth with economic conditions. Performance against quality benchmarks was also monitored, with opioid-related overdose deaths decreasing by nearly 40% in 2024, indicating systemic improvements. Although the state exceeded benchmarks in two quality measures, other areas such as emergency department use and preventive screenings showed progress but did not meet benchmarks.
Challenges persist in areas like adult obesity, statin therapy adherence, and cervical cancer screening within the commercial sector. Despite some benchmarks remaining unmet, DHSS highlighted ongoing progress in critical areas, indicating opportunities for further improvement. For more detailed insights, an interactive quality and spending dashboard, updated with 2024 data, is available online.